Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: BOSTON MEDICAL CENTER CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-24 to 2024-01-15
Current total value of award: $516465.72
Description: TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS AND THE PHARMACODYNAMIC EFFECTS, CYCLE CONTROL, AND SAFETY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG-ACTING INJECTABLE.